June 08-12, 2020
Virtual Event
The annual convention of the BIO, the largest trade association representing the biopharmaceutical industry is this year in virtual event format as BIO Digital. Please use the One-on-One Partnering to meet with Thomas Schirrmann (CEO), André Frenzel (CSO), Linda Kirchner (Business Development) or David Passmore (Business Development) to learn more about YUMAB’s fully human antibody technology platform, its potential in drug discovery and development, and the company’s diverse business opportunities. Arrange a meeting
People attending from YUMAB:
David Passmore, PhD
Business Development
